SIGILON THERAPEUTICS INC - COM (SGTX)

CUSIP: 82657L107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
9,251,566
Share change
-13,617
Total reported value
$206,747,409
Price per share
$22.35
Number of holders
50
Value change
-$24,604,312
Number of buys
29
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 82657L107?
CUSIP 82657L107 identifies SGTX - SIGILON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SIGILON THERAPEUTICS INC - COM (SGTX) as of Q1 2021

As of 31 Mar 2021, SIGILON THERAPEUTICS INC - COM (SGTX) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,251,566 shares. The largest 10 holders included CANADA PENSION PLAN INVESTMENT BOARD, BlackRock Inc., Avidity Partners Management LP, FMR LLC, HarbourVest Partners LLC, GILDER GAGNON HOWE & CO LLC, STATE OF WISCONSIN INVESTMENT BOARD, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.